Buy FRAG 176-191 Peptide for Sale
Product Specifications
| Category | Details |
|---|---|
| Peptide Name | FRAG 176-191 (HGH Fragment 176-191) |
| Purity | 99%+ pharmaceutical grade |
| Available Vial Size | 2mg vials |
| Molecular Formula | C78H123N23O23S2 |
| Molecular Weight | 1817 g/mol |
| Administration | Subcutaneous injection (research use only) |
| Storage | Store refrigerated at 2-8°C |
What is FRAG 176-191?
FRAG 176-191, also known as HGH Fragment 176-191, is a modified segment of the full human growth hormone molecule (amino acids 176-191). It was specifically developed to isolate the fat-burning properties of HGH without triggering the broader hormonal effects associated with full growth hormone use. In research models, FRAG 176-191 has shown strong lipolytic activity, promoting body fat reduction—particularly in stubborn adipose tissue—without influencing blood sugar, IGF-1 levels, or causing water retention, making it a highly targeted tool for fat loss research.
How Does FRAG 176-191 Work?
FRAG 176-191 works by directly stimulating lipolysis (fat breakdown) while inhibiting lipogenesis (fat formation). Unlike full HGH, which affects multiple metabolic systems, this isolated fragment focuses primarily on body composition changes:
-
Activates beta-adrenergic pathways to increase fat breakdown
-
Reduces new fat accumulation while promoting fat oxidation
-
Preserves lean muscle mass during calorie deficits
-
Avoids insulin resistance, blood sugar fluctuations, or unwanted water retention
-
Supports fat loss from resistant areas such as abdomen and lower body
Its highly selective action makes it ideal for studies focused solely on targeted body fat reduction.
FRAG 176-191 Benefits
-
Significant fat loss without muscle loss
-
Targets stubborn fat areas resistant to diet and training
-
Non-diabetogenic — does not raise blood glucose or insulin resistance
-
No water retention or bloating
-
Supports lean body recomposition
-
Extremely well-tolerated in most research protocols
-
Does not stimulate overall growth hormone systemic effects
FRAG 176-191 Dosage (Research Purposes Only)
-
Standard Dosage: 250mcg to 500mcg daily
-
Advanced Dosage: Up to 1000mcg daily (divided doses)
-
Administration: Subcutaneous injection, ideally pre-workout or in the morning
-
Cycle Length: 4 to 12 weeks depending on study protocol
Many protocols recommend splitting daily dosages into multiple injections to maintain optimal serum levels during research periods.
Potential Side Effects
FRAG 176-191 is one of the safest peptides in current fat loss research models. Potential minor side effects include:
-
Temporary injection site irritation
-
Rare mild hunger increases (transient)
-
Very low risk of systemic side effects seen with full HGH
-
No IGF-1 elevation or blood sugar fluctuations reported
Its non-hormonal nature makes it highly suitable for long-term body fat studies.
Why Researchers Buy FRAG 176-191 from AnabolicPharm
AnabolicPharm supplies pharmaceutical-grade FRAG 176-191, fully lab-tested for purity, concentration, and stability. Researchers trust AnabolicPharm for clean, clinical-grade peptides specifically designed for advanced fat loss research, body composition optimization, and metabolic regulation models.
Each vial is manufactured to strict standards, properly labeled, and shipped worldwide with fast, professional handling for serious scientific studies.

Reviews
There are no reviews yet.